Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Understanding the Propagation of Closed Circular Extrachromosomal rDNA Containing Element (CERE) in Naegleria gruberi
Published on: June 21, 2024
Naegleria fowleri: pathogenesis, diagnosis, and treatment options
Eddie Grace1, Scott Asbill1, Kris Virga2
1Presbyterian College School of Pharmacy, Clinton, South Carolina, USA.
Abstract:
Naegleria fowleri has generated tremendous media attention over the last 5 years due to several high-profile cases. Several of these cases were followed very closely by the general public. N. fowleri is a eukaryotic, free-living amoeba belonging to the phylum Percolozoa. Naegleria amoebae are ubiquitous in the environment, being found in soil and bodies of freshwater, and feed on bacteria found in those locations. While N. fowleri infection appears to be quite rare compared to other diseases, the clinical manifestations of primary amoebic meningoencephalitis are devastating and nearly always fatal. Due to the rarity of N. fowleri infections in humans, there are no clinical trials to date that assess the efficacy of one treatment regimen over another. Most of the information regarding medication efficacy is based on either case reports or in vitro studies. This review will discuss the pathogenesis, diagnosis, pharmacotherapy, and prevention of N. fowleri infections in humans, including a brief review of all survivor cases in North America.
Insights
Naegleria fowleri, a rare but deadly brain-eating amoeba, causes primary amoebic meningoencephalitis. This review covers its pathogenesis, diagnosis, treatment, and prevention, including North American survivor cases.
Area of Science:
- Infectious Diseases
- Neuroparasitology
- Public Health
Background:
- Naegleria fowleri is a free-living amoeba found in warm freshwater and soil.
- Infections, though rare, lead to primary amoebic meningoencephalitis (PAM), a devastating and nearly always fatal neurological disease.
- Recent high-profile cases have increased public awareness.
Purpose of the Study:
- To review the pathogenesis, diagnosis, pharmacotherapy, and prevention of Naegleria fowleri infections in humans.
- To discuss treatment strategies based on limited clinical data.
- To review documented survivor cases in North America.
Main Methods:
- Literature review of case reports and in vitro studies on Naegleria fowleri.
- Analysis of clinical manifestations and treatment outcomes.
- Compilation of information on prevention strategies.
Main Results:
- Primary amoebic meningoencephalitis (PAM) has a high mortality rate.
- Treatment efficacy data is primarily derived from case reports and in vitro studies due to the rarity of human infections.
- Few documented cases of human survivors exist, offering limited insights into effective treatment.
Conclusions:
- Effective treatment strategies for Naegleria fowleri infections are not well-established due to limited clinical trial data.
- Early diagnosis and prompt initiation of available therapeutic options are crucial.
- Further research, including case studies of survivors, is needed to improve treatment outcomes and prevention measures.
Related Concept Videos
Viral Meningitis
Acute Pyelonephritis II: Diagnostic Studies and Management
Arboviral Encephalitis
Fungal Phylum Microsporidia
Diphtheria
Urinary Tract Infection IV: Nursing Management

